Theuretzbacher U - Search Results

1

Combination therapy for carbapenem-resistant Gram-negative bacteria.

Paul M, Carmeli Y, Durante-Mangoni E, Mouton JW, Tacconelli E, Theuretzbacher U, Mussini C, Leibovici L. Paul M, et al. Among authors: theuretzbacher u. J Antimicrob Chemother. 2014 Sep;69(9):2305-9. doi: 10.1093/jac/dku168. Epub 2014 May 28. J Antimicrob Chemother. 2014. PMID: 24872346 Review.

2

Tissue concentrations: do we ever learn?

Mouton JW, Theuretzbacher U, Craig WA, Tulkens PM, Derendorf H, Cars O. Mouton JW, et al. Among authors: theuretzbacher u. J Antimicrob Chemother. 2008 Feb;61(2):235-7. doi: 10.1093/jac/dkm476. Epub 2007 Dec 6. J Antimicrob Chemother. 2008. PMID: 18065413 Review.

3

Future antibiotics scenarios: is the tide starting to turn?

Theuretzbacher U. Theuretzbacher U. Int J Antimicrob Agents. 2009 Jul;34(1):15-20. doi: 10.1016/j.ijantimicag.2009.02.005. Epub 2009 Apr 1. Int J Antimicrob Agents. 2009. PMID: 19342202 Review.

4

Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.

Mouton JW, Ambrose PG, Canton R, Drusano GL, Harbarth S, MacGowan A, Theuretzbacher U, Turnidge J. Mouton JW, et al. Among authors: theuretzbacher u. Drug Resist Updat. 2011 Apr;14(2):107-17. doi: 10.1016/j.drup.2011.02.005. Epub 2011 Mar 26. Drug Resist Updat. 2011. PMID: 21440486 Review.

5

Protein binding: do we ever learn?

Zeitlinger MA, Derendorf H, Mouton JW, Cars O, Craig WA, Andes D, Theuretzbacher U. Zeitlinger MA, et al. Among authors: theuretzbacher u. Antimicrob Agents Chemother. 2011 Jul;55(7):3067-74. doi: 10.1128/AAC.01433-10. Epub 2011 May 2. Antimicrob Agents Chemother. 2011. PMID: 21537013 Free PMC article. Review.

6

Update on antibacterial and antifungal drugs - can we master the resistance crisis?

Theuretzbacher U, Mouton JW. Theuretzbacher U, et al. Curr Opin Pharmacol. 2011 Oct;11(5):429-32. doi: 10.1016/j.coph.2011.08.002. Epub 2011 Sep 6. Curr Opin Pharmacol. 2011. PMID: 21903474 No abstract available.

7

Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.

Pulcini C, Bush K, Craig WA, Frimodt-Møller N, Grayson ML, Mouton JW, Turnidge J, Harbarth S, Gyssens IC; ESCMID Study Group for Antibiotic Policies. Pulcini C, et al. Clin Infect Dis. 2012 Jan 15;54(2):268-74. doi: 10.1093/cid/cir838. Clin Infect Dis. 2012. PMID: 22198992 Review.

8

Accelerating resistance, inadequate antibacterial drug pipelines and international responses.

Theuretzbacher U. Theuretzbacher U. Int J Antimicrob Agents. 2012 Apr;39(4):295-9. doi: 10.1016/j.ijantimicag.2011.12.006. Epub 2012 Feb 14. Int J Antimicrob Agents. 2012. PMID: 22341298 Review.

9

Consistent global approach on reporting of colistin doses to promote safe and effective use.

Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD. Nation RL, et al. Among authors: theuretzbacher u. Clin Infect Dis. 2014 Jan;58(1):139-41. doi: 10.1093/cid/cit680. Epub 2013 Oct 8. Clin Infect Dis. 2014. PMID: 24107410 No abstract available.

10

Product information for parenteral colistin varies substantially across Europe.

Theuretzbacher U. Theuretzbacher U. J Antimicrob Chemother. 2014 Jul;69(7):1987-92. doi: 10.1093/jac/dku064. Epub 2014 Mar 14. J Antimicrob Chemother. 2014. PMID: 24633204

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters